Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079326
Status:
TERMINATED
Last Update Posted:
2014-06-02
First Post:
2004-03-08
Brief Title:
Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer
Sponsor:
Organization:
National Cancer Institute NCI